v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (36,706) $ (67,175)
Adjustments to reconcile net loss to net cash from operating activities    
Depreciation, amortization, and impairment 26,766 51,302
Inventory reserve expenses 8,010 25,393
Amortization of operating lease assets, debt costs, and other assets 2,146 2,377
Provision for expected credit losses 3,591 1,837
Deferred income taxes 432 12
Share-based compensation expense 14,268 14,293
Loss on disposal of fixed assets 404 581
Change in valuation of investment securities (16) (31)
Change in fair value of contingent consideration 1,618 (1,373)
Other 890 (1,188)
Changes in operating assets and liabilities    
Accounts receivable (4,079) 5,089
Inventories (20,925) (5,890)
Prepaid expenses and other current assets 2,144 (394)
Accounts payable 484 (9,138)
Other current liabilities (22,784) (21,763)
Other long-term assets and liabilities (77) (684)
Net cash used in operating activities (23,834) (6,752)
Cash flows from investing activities    
Capital expenditures (23,308) (13,845)
Other investing activities 146 12
Net cash used in investing activities (23,162) (13,833)
Cash flows from financing activities    
Proceeds from issuance of common shares 2,626 3,054
Payments related to tax withholdings for share-based compensation (150) (159)
Payments related to finance lease obligation (56) (375)
Borrowings under credit facility 64,025  
Payment of debt issuance costs and other financing activities (24) (531)
Net cash provided by financing activities 66,421 1,989
Effect of exchange rate changes on cash (135) 1,547
Net change in cash and cash equivalents 19,290 (17,049)
Cash, cash equivalents, and restricted cash at the beginning of period 85,115 85,738
Cash, cash equivalents, and restricted cash at the end of period 104,405 68,689
Components of cash, cash equivalents, and restricted cash at the end of period    
Cash and cash equivalents 103,810 65,606
Restricted cash 595 3,083
Cash, cash equivalents, and restricted cash at the end of period 104,405 68,689
Noncash investing activities - Accrued purchases of capital expenditures $ 17,696 10,990
Noncash investing activities - Purchase of intangible assets   $ 40